# Diacerin for the Treatment of Epidermolysis Bullosa Simplex

> **NCT02470689** · PHASE2 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Epidermolysis Bullosa Simplex

## Interventions

- **DRUG:** Diacerin cream

## Key facts

- **NCT ID:** NCT02470689
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2017-12
- **Final completion:** —
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2015-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02470689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02470689, "Diacerin for the Treatment of Epidermolysis Bullosa Simplex". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02470689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*